Lykos Therapeutics (formerly MAPS PBC)
Judy Calkins has extensive experience in finance and accounting, currently serving as Corporate Controller at Lykos Therapeutics since June 2020, where the focus is on psychedelic drug development and public benefit. Judy Calkins is the Owner and CFO of JC Accounting since 2008 and previously held significant roles including Financial Controller at Terra Education, Inc. from 2012 to 2020, Director of Finance & Administration at the San Diego North Convention & Visitors Bureau, and various financial leadership positions in the hospitality industry including Controller roles at US Grant Hotel and Hilton Gaslamp. Judy Calkins began a career in finance at Sheraton Torrey Pines and has progressively taken on more responsibilities across multiple organizations. Educational background includes studies at California State Polytechnic University-Pomona.
This person is not in the org chart
Lykos Therapeutics (formerly MAPS PBC)
At Lykos Therapeutics, our mission is to transform the way mental health is treated. We aspire to challenge the status quo through the development of novel therapies and therapeutic approaches to treat mental health conditions. With 30+ years of experience researching psychedelic-assisted therapies, we remain focused on following rigorous science from which we can develop and commercialize novel treatment options. Founded in 2014 by the non-profit Multidisciplinary Association for Psychedelic Studies (“MAPS”), we are a for-profit public benefit corporation (“PBC”). As a PBC, we consider the impact of our decisions on society just as we think about financial implications. Everything we do is looked at through a public benefit lens. To learn more, visit us at www.lykospbc.com.